{
    "eid": "2-s2.0-85123466103",
    "title": "Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Core antigen",
        "Dialyzer reuse",
        "Genotype",
        "HCV",
        "Hemodialysis",
        "Transmission"
    ],
    "authors": [
        "Natthaya Chuaypen",
        "Apichaya Khlaiphuengsin",
        "Thaninee Prasoppokakorn",
        "Paweena Susantitaphong",
        "Wisit Prasithsirikul",
        "Anchalee Avihingsanon",
        "Pisit Tangkijvanich",
        "Kearkiat Praditpornsilpa"
    ],
    "citedby-count": 7,
    "ref-count": 45,
    "ref-list": [
        "Hepatitis C",
        "Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource",
        "Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 national survey",
        "Epidemiology and natural history of HCV infection",
        "Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis",
        "Hepatitis C virus and the kidney",
        "What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection?",
        "Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention",
        "The epidemiology of HCV infection in patients with advanced CKD/ESRD: a global perspective",
        "KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease",
        "Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis",
        "HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies",
        "Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis",
        "Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays",
        "Phylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region",
        "Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia",
        "A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences",
        "Patterns of Hepatitis C Virus Transmission in Human Immunodeficiency Virus (HIV)-infected and HIV-negative Men Who Have Sex With Men",
        "2018 kidney disease: improving global outcomes (KDIGO) Hepatitis C in chronic kidney disease guideline implementation: Asia Summit Conference Report",
        "Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand",
        "Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients",
        "An investigation of an outbreak of hepatitis C virus infections in a low-resourced hemodialysis unit in Vietnam",
        "Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants",
        "Hepatitis C: global epidemiology and strategies for control",
        "Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels",
        "Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data",
        "Factors correlating to the development of hepatitis C virus infection in hemodialysis patients-findings mainly from asiatic populations: a systematic review and meta-analysis",
        "A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit",
        "Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit",
        "Use of genome sequencing to identify hepatitis C virus transmission in a renal healthcare setting",
        "Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management",
        "Prevention, diagnosis, evaluation, and treatment of hepatitis C virus infection in chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2018 clinical practice guideline",
        "Who to test and how to test for chronic hepatitis C infection\u20142016 WHO testing guidance for low- and middle-income countries",
        "HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis",
        "Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients",
        "Hepatitis C virus core antigen testing in liver and kidney transplant recipients",
        "The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism",
        "Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment",
        "Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4\u20135 chronic kidney disease (the C-SURFER study): a combination phase 3 study",
        "Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function",
        "Towards eradication of hepatitis C virus from dialysis units",
        "Noninvasive methods to assess liver disease in patients with hepatitis B or C",
        "Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection",
        "Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "106545448",
            "affilname": "Bamrasnaradura Infectious Diseases Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106545448",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Hepatitis and Liver Cancer",
        "Detudom Royal Crown Prince Hospital",
        "Kesara Chulaphan",
        "Khon Kaen Hospital",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}